Inhibition of cell growth by K+ channel modulators is due to interference with agonist-induced Ca2+ release

Area of Science:

• Neuro-oncology
• Cellular physiology
• Ion channel pharmacology

Background:

• Brain tumors, including astrocytoma and neuroblastoma, exhibit uncontrolled cell proliferation.
• Ion channels, particularly potassium (K+) channels, play critical roles in cell function and regulation.
• Modulation of K+ channels represents a potential strategy for targeting cancer cell growth.

Purpose of the Study:

• To investigate the impact of K+ channel modulators (tetraethylammonium, 4-aminopyridine, diazoxide) and high extracellular K+ on brain tumor cell lines.
• To determine the effect of these agents on cell growth and intracellular calcium (Ca2+) mobilization.
• To explore the potential of K+ channel modulation as a therapeutic strategy for brain tumors.

Main Methods:

• Utilized two human brain tumor cell lines: U-373 MG astrocytoma and SK-N-MC neuroblastoma.
• Administered K+ channel modulators and varied extracellular K+ concentrations.
• Assessed cell growth inhibition and measured agonist-induced intracellular Ca2+ mobilization.

Main Results:

• K+ channel modulators and elevated extracellular K+ significantly inhibited tumor cell growth in a dose-dependent manner for both cell lines.
• Pretreatment with growth-inhibitory concentrations of K+ channel modulators or high extracellular K+ blocked agonist-induced intracellular Ca2+ mobilization.
• A correlation was observed between growth inhibition and interference with Ca2+ signaling pathways.

Conclusions:

• K+ channel modulators are effective inhibitors of human brain tumor cell growth.
• The growth-regulatory effects may be mediated by the disruption of intracellular Ca2+ signaling mechanisms.
• These findings highlight the potential of targeting K+ channels for brain tumor therapy.